Application of engineered extracellular vesicles for targeted tumor therapy

Area of Science:

• Biotechnology
• Nanomedicine
• Oncology

Background:

• Extracellular vesicles (EVs) are released by all cell types and mediate intercellular communication.
• EVs contain diverse biomolecules (RNA, proteins) and possess inherent properties like targeting specificity and durability.
• These characteristics make EVs promising candidates for drug delivery and precision therapies, particularly in oncology.

Purpose of the Study:

• To review isolation and engineering techniques for extracellular vesicles (EVs).
• To evaluate the therapeutic potential of EVs in cancer treatment.
• To discuss advancements in engineered EVs and co-delivery systems for improved cancer therapy.

Main Methods:

• Literature review of EV isolation and modification technologies.
• Analysis of studies on EV-based drug delivery for tumors.
• Examination of engineered EVs and co-delivery systems (hydrogels, liposomes).

Main Results:

• EVs can be engineered to enhance drug delivery and targeting for cancer therapy.
• EVs can modulate the tumor microenvironment and immune response to inhibit tumor progression.
• Co-delivery systems involving EVs show potential for improved therapeutic efficacy.

Conclusions:

• Engineered extracellular vesicles offer a promising platform for advanced cancer treatment strategies.
• EVs, particularly when combined with co-delivery systems, represent a significant advancement in precision oncology.
• Further research into EV engineering and delivery systems can optimize their clinical application in cancer therapy.